Increased Circulating Proinflammatory T Lymphocytes in Children with Different Forms of Anterior Uveitis: Results from a Pilot Study

References

• Simonini G, Cantarini L, Bresci C, Lorusso M, Galeazzi M, Cimaz R. Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev. 2010;9(10):674–683.
   PubMed Web of Science ®Google Scholar
• Vastert SJ, Bhat P, Goldstein DA. Pathophysiology of JIA-associated uveitis. Ocul Immunol Inflamm. 2014;22(5):414–423.
   PubMed Web of Science ®Google Scholar
• Kalinina Ayuso V, Makhotkina N, Van Tent-Hoeve M, et al. Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown. Surv Ophthalmol. 2014;59(5):517–531.
   PubMed Web of Science ®Google Scholar
• Forrester JV, Klaska IP, Yu T, Kuffova L. Uveitis in mouse and man. Int Rev Immunol. 2013;32(1):76–96.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–392.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology. 2007;46(6):1015–1019.
   PubMed Web of Science ®Google Scholar
• Murphy CC, Duncan L, Forrester JV, Dick AD. Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis. Br J Ophthalmol. 2004;88(3):412–416.
   PubMed Web of Science ®Google Scholar
• Kilmartin DJ, Fletcher ZJ, Almeida JA, Liversidge J, Forrester JV, Dick AD. CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis. Invest Ophthalmol Vis Sci. 2001;42(6):1285–1292.
   PubMed Web of Science ®Google Scholar
• Zou W, Wu Z, Xiang X, Sun S, Zhang J. The expression and significance of T helper cell subsets and regulatory T cells CD4+CD25+ in peripheral blood of patients with human leukocyte antigen B27-positive acute anterior uveitis. Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2014;252(4):665–672.
   PubMed Web of Science ®Google Scholar
• Hirahara K, Nakayama T. CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol. 2016;28(4):163–171.
   PubMed Web of Science ®Google Scholar
• Caspi RR. Understanding autoimmune uveitis through animal models. The Friedenwald Lecture. Invest Ophthalmol Vis Sci. 2011;52(3):1872–1879.
   PubMed Web of Science ®Google Scholar
• Wu S-A, Yeh K-W, Lee W-I, Yao T-C, Huang J-L. Persistent improper upregulation of Th17 and TReg cells in patients with juvenile idiopathic arthritis. J Microbiol Immunol Infect. 2016;49(3):402–408.
   PubMedGoogle Scholar
• Cosmi L, Cimaz R, Maggi L, et al. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(8):2504–2515.
   PubMedGoogle Scholar
• Guggino G, Giardina A, Ferrante A, et al. The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis. Rheumatol Int. 2015;35(1):171–175.
   PubMed Web of Science ®Google Scholar
• Li Y, Jiang L, Zhang S, et al. Methotrexate attenuates the Th17/IL-17 levels in peripheral blood mononuclear cells from healthy individuals and RA patients. Rheumatol Int. 2012;32(8):2415–2422.
   PubMed Web of Science ®Google Scholar
• Bulatovic Calasan M, Vastert SJ, Scholman RC, et al. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis. Rheumatology (Oxford). 2015;54(9):1724–1734.
   PubMed Web of Science ®Google Scholar
• Pesenacker AM, Wedderburn LR. T regulatory cells in childhood arthritis–novel insights. Expert Rev Mol Med. 2013;15:e13.
   PubMed Web of Science ®Google Scholar
• Bai A, Moss A, Kokkotou E, et al. CD39 and CD161 modulate Th17 responses in Crohn’s disease. J Immunol. 2014;193(7):3366–3377.
   PubMed Web of Science ®Google Scholar
• Miao J, Zhang K, Lv M, et al. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis. Scand J Rheumatol. 2014;43(3):194–201.
   PubMed Web of Science ®Google Scholar
• Cosmi L, De Palma R, Santarlasci V, et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med. 2008;205(8):1903–1916.
   PubMed Web of Science ®Google Scholar
• Pesenacker AM, Bending D, Ursu S, Wu Q, Nistala K, Wedderburn LR. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood. 2013;121(14):2647–2658.
   PubMed Web of Science ®Google Scholar
• Silosi I, Boldeanu MV, Cojocaru M, et al. The relationship of Cytokines IL-13 and IL-17 with autoantibodies profile in early rheumatoid arthritis. J Immunol Res. 2016;2016:3109135.
   PubMedGoogle Scholar
• De Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007;66(5):589–598.
   PubMed Web of Science ®Google Scholar
• Horai R, Caspi RR. Cytokines in autoimmune uveitis. J Interferon Cytokine Res. 2011;31(10):733–744.
   PubMed Web of Science ®Google Scholar
• Wang J, Ma L, Yang S, Wang S, Wei X, Song S. IL-10-expressing Th2 cells contribute to the elevated antibody production in rheumatoid arthritis. Inflammation. 2016;39(3):1017–1024.
   PubMed Web of Science ®Google Scholar
• Walscheid K, Hennig M, Heinz C, et al. Correlation between disease severity and presence of ocular autoantibodies in juvenile idiopathic arthritis-associated uveitis. Invest Ophthalmol Vis Sci. 2014;55(6):3447–3453.
   PubMed Web of Science ®Google Scholar
• Calleja S, Cordero-Coma M, Rodriguez E, Llorente M, Franco M. Ruiz de Morales JG. Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study. Eye (London, England). 2012;26(3):468–477.
   PubMed Web of Science ®Google Scholar
• Moncrieffe H, Nistala K, Kamhieh Y, et al. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol. 2010;185(1):134–143.
   PubMed Web of Science ®Google Scholar
• Bi H-S, Liu Z-F, Cui Y. Pathogenesis of innate immunity and adaptive immunity in the mouse model of experimental autoimmune uveitis. J Chin Med Association: JCMA. 2015;78(5):276–282.
   PubMed Web of Science ®Google Scholar
• Berkun Y, Bendersky A, Gerstein M, Goldstein I, Padeh S, Bank I. T cells in juvenile idiopathic arthritis: higher percentages of synovial V 1+ and V 9+ T cell subsets are associated with milder disease. J Rheumatol. 2011;38(6):1123–1129.
   PubMed Web of Science ®Google Scholar
• Massa M, De Benedetti F, Robbioni P, Ramenghi B, Albani S, Martini A. Association of methotrexate treatment with a decrease of double negative (CD4-CD8-) and gamma/delta T cell levels in patients with juvenile rheumatoid arthritis. J Rheumatol. 1993;20(11):1944–1948.
   PubMed Web of Science ®Google Scholar
• Kessel C, Lippitz K, Weinhage T, et al. Pro-inflammatory cytokine environments can drive IL-17 over-expression by gammadeltaT cells in systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2017;69(7):1480–1494.
   PubMedGoogle Scholar